Name: Quince Therapeutics, Inc. (QNCX) Balance Sheet
Creator: FinSpry

Quince Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Quince Therapeutics, Inc. (QNCX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	6.21	20.75	44.58	69.72	66.84	99.86
Short-Term Investments	34.57	54.31	45.60	37.08	66.98	0.00
Cash & Short-Term Investments	40.78	75.06	90.18	106.80	133.82	99.86
Accounts Receivable	0.88	0.99	1.00	1.13	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.08	0.08	1.20	0.37	1.24	1.06
Total Current Assets	44.04	77.44	93.75	111.67	137.86	106.06
Non-Current Assets
Property, Plant & Equipment (Net)	0.81	0.62	0.68	1.43	1.10	0.63
Long-Term Investments	0.08	0.08	3.58	19.93	50.46	0.00
Goodwill	0.00	17.63	0.00	0.00	0.00	0.00
Intangible Assets	60.05	63.67	5.90	0.00	0.00	0.00
Other Non-Current Assets	9.51	0.01	0.00	0.19	0.04	0.22
Total Non-Current Assets	70.44	90.46	10.16	21.56	51.60	17.61
Total Assets	114.48	167.90	103.91	133.23	189.47	124.37
Current Liabilities
Accounts Payable	2.90	2.03	0.57	4.91	3.56	8.89
Short-Term Debt	0.19	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	3.97	3.12	1.86	8.39	13.16	0.00
Other Current Liabilities	0.31	4.36	0.19	0.18	0.04	0.00
Total Current Liabilities	7.28	9.57	3.07	14.22	17.00	8.89
Non-Current Liabilities
Long-Term Debt	14.32	13.43	0.00	0.42	0.21	0.00
Deferred Tax Liabilities	4.96	5.30	0.25	0.00	0.00	0.00
Other Non-Current Liabilities	57.38	54.19	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	77.05	73.24	0.25	0.42	0.21	0.00
Total Liabilities	84.33	82.82	3.32	14.64	17.20	8.89
Stockholders' Equity
Common Stock	0.04	0.04	0.04	0.03	0.03	0.00
Retained Earnings	-376.47	-319.64	-288.26	-236.60	-146.65	-69.81
Accumulated Other Comprehensive Income	-0.04	3.05	-0.29	-0.08	0.31	0.06
Additional Paid-in Capital	406.61	401.64	389.11	355.23	318.57	185.20
Shares Outstanding	44.00	42.97	36.14	30.07	0.00	0.00
Total Stockholders' Equity	30.15	85.08	100.59	118.59	172.26	115.48
Total Liabilities & Equity	114.48	167.90	103.91	133.23	189.47	124.37